Skip to main content

PPN World · Archive

Reserved for subscribers

This release sits in the PPN World archive. Subscribers read the full wire as it lands — 400+ newswires, 190+ countries, searchable back through the archive, with alerts on the subjects they track.

  • · Every release, the moment it crosses — not a daily digest
  • · Search and filter the full archive, not the last 24 hours
  • · Instant alerts on saved searches

PPN World — real-time press release intelligence.

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Completes Patient Enrollment in Phase II Study for Biliary Tract Cancer, Further Demonstrating Breakthrough Potential in Immune-Cold Tumors · GlobeNewswire · PPN World